Pancreatoduodenectomy Clinical Trial
Official title:
Internal Biodegradable Stent Versus Non-Stent in Patients at High-Risk of Developing Fistula After Pancreatoduodenectomy (BioSteP): a Randomized Controlled Study
The aim of this randomized controlled study is to compare the efficacy of biodegradable internal pancreatic stenting versus no stenting in patients undergoing pancreatoduodenectomy (PD), focusing on a possible superiority association of the device in preventing clinically relevant postoperative pancreatic fistula (CR-POPF). Patients undergoing PD will be randomized into two arms: - arm 1: a biodegradable internal pancreatic stent will be placed at the level of the pancreatic anastomosis - arm 2: no pancreatic stent will be placed at the level of the pancreatic anastomosis The rate of occurrence of CR-POPF will be compared between the two arms.
Clinically relevant postoperative pancreatic fistula (CR-POPF) represents the most common complication that can occur after pancreatoduodenectomy (PD). CR-POPF is the main cause of morbidity after PD, being associated with a risk of mortality up to 60%. The placement of external or internal pancreatic stents after PD have been investigated as possible strategies for preventing the development of CR-POPF. However, device displacement has been reported as a common cause of pancreatic stents malfunction. Recently, a novel biodegradable pancreatic stent (ARCHIMEDES™) has been introduced. The device has been specifically designed to reduce the risk of displacement, thus offering a new valuable tool to decrease the rate of CR-POPF after PD. In this randomised, controlled, single-center trial, researchers investigate the possible efficacy of biodegradable internal pancreatic stenting of pancreatic anastomosis in patient undergoing PD versus no stenting, focusing on a possible superiority association for preventing CR-POPF. Participants will be randomised into two arms (Biodegradable stent vs non-stent) based on their intra-operative risk of developing POPF according to the Fistula Risk Score (FRS). The rate of CR-POPF will be compared between the two arms. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06289803 -
The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery
|
N/A | |
Completed |
NCT05109143 -
Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy
|
N/A | |
Completed |
NCT02588066 -
Pancreatoduodenectomy With or Without Ligamentum Teres Wrap Around Gastroduodenal Artery Stump for Prevention of Pancreatic Hemorrhage
|
N/A | |
Completed |
NCT01984216 -
Billroth II Versus Roux-en-Y for the Gastrojejunostomy in the Pancreatoduodenectomy
|
N/A | |
Not yet recruiting |
NCT06319755 -
Characteristics of Intestinal Microbiome Following Pancreatic Surgery
|
||
Recruiting |
NCT05703581 -
Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy
|
||
Not yet recruiting |
NCT05895214 -
Mesopancreas Study in Pancreatic Cancer
|
||
Completed |
NCT03850236 -
Neck Division Level and Postoperative Pancreatic Fistula After Pancreaticoduodenectomy
|
||
Not yet recruiting |
NCT03754595 -
Application of 2D and 3D Laparoscopy in Laparoscopic Pancreaticoduodenectomy: a Prospective Randomized Clinical Trial
|
N/A | |
Completed |
NCT05573399 -
Early Oral Feeding for Patients After Pancreaticoduodenectomy
|
||
Completed |
NCT04381702 -
Outcome After Laparoscopic Versus Open Pancreaticoduodenectomy
|